<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Busek M</submitter><funding>European Union</funding><funding>The Research Council of Norway</funding><pagination>126</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8869899</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>12(2)</volume><pubmed_abstract>Organ-on-a-Chip (OoC) systems bring together cell biology, engineering, and material science for creating systems that recapitulate the in vivo microenvironment of tissues and organs. The versatility of OoC systems enables in vitro models for studying physiological processes, drug development, and testing in both academia and industry. This paper evaluates current platforms from the academic end-user perspective, elaborating on usability, complexity, and robustness. We surveyed 187 peers in 35 countries and grouped the responses according to preliminary knowledge and the source of the OoC systems that are used. The survey clearly shows that current commercial OoC platforms provide a substantial level of robustness and usability-which is also indicated by an increasing adaptation of the pha</pubmed_abstract><journal>Biosensors</journal><pubmed_title>Academic User View: Organ-on-a-Chip Technology.</pubmed_title><pmcid>PMC8869899</pmcid><funding_grant_id>Marie Skłodowska-Curie Actions Grant agreement No 801133</funding_grant_id><funding_grant_id>Centers of Excellence scheme, project number 262613</funding_grant_id><pubmed_authors>Delon L</pubmed_authors><pubmed_authors>Busek M</pubmed_authors><pubmed_authors>Krauss S</pubmed_authors><pubmed_authors>Aizenshtadt A</pubmed_authors><pubmed_authors>Amirola-Martinez M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Academic User View: Organ-on-a-Chip Technology.</name><description>Organ-on-a-Chip (OoC) systems bring together cell biology, engineering, and material science for creating systems that recapitulate the in vivo microenvironment of tissues and organs. The versatility of OoC systems enables in vitro models for studying physiological processes, drug development, and testing in both academia and industry. This paper evaluates current platforms from the academic end-user perspective, elaborating on usability, complexity, and robustness. We surveyed 187 peers in 35 countries and grouped the responses according to preliminary knowledge and the source of the OoC systems that are used. The survey clearly shows that current commercial OoC platforms provide a substantial level of robustness and usability-which is also indicated by an increasing adaptation of the pha</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Feb</publication><modification>2025-04-25T22:30:04.556Z</modification><creation>2025-02-19T03:47:02.581Z</creation></dates><accession>S-EPMC8869899</accession><cross_references><pubmed>35200386</pubmed><doi>10.3390/bios12020126</doi></cross_references></HashMap>